EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents

Michelle Sharp, Seamas C Donnelly, David R Moller

Respiratory Medicine: X · 2019

DOI: 10.1016/j.yrmex.2019.100004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Medicine: X, 2019. Verfasst von Michelle Sharp und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• Tocilizumab may represent a novel therapy in patients with sarcoidosis. • Our hypothesis is IL6 receptor inhibition blocks sarcoidosis granuloma formation. • Formal clinical trials of IL6 inhibitory therapies should be considered.

Autor:innen und Institutionen

  • Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Department of Medicine, Trinity College Dublin and Tallaght University Hospital, Dublin, Ireland.

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Sharp, M., Donnelly, S. C., & Moller, D. R. (2019). Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents. Respiratory Medicine: X. https://doi.org/10.1016/j.yrmex.2019.100004

Vancouver

Sharp M, Donnelly SC, Moller DR. Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents. Respiratory Medicine: X. 2019. doi:10.1016/j.yrmex.2019.100004

BibTeX
@article{Sharp2019,
  author = {Sharp, Michelle and Donnelly, Seamas C and Moller, David R},
  title = {Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents},
  journal = {Respiratory Medicine: X},
  year = {2019},
  doi = {10.1016/j.yrmex.2019.100004}
}
Kostenlos starten →